1. Home
  2. PFAI vs RANI Comparison

PFAI vs RANI Comparison

Compare PFAI & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFAI
  • RANI
  • Stock Information
  • Founded
  • PFAI 2015
  • RANI 2012
  • Country
  • PFAI Canada
  • RANI United States
  • Employees
  • PFAI N/A
  • RANI N/A
  • Industry
  • PFAI Farming/Seeds/Milling
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • PFAI Consumer Staples
  • RANI Health Care
  • Exchange
  • PFAI Nasdaq
  • RANI Nasdaq
  • Market Cap
  • PFAI 21.1M
  • RANI 24.2M
  • IPO Year
  • PFAI 2025
  • RANI 2021
  • Fundamental
  • Price
  • PFAI $3.62
  • RANI $1.64
  • Analyst Decision
  • PFAI
  • RANI Strong Buy
  • Analyst Count
  • PFAI 0
  • RANI 4
  • Target Price
  • PFAI N/A
  • RANI $7.75
  • AVG Volume (30 Days)
  • PFAI 3.3M
  • RANI 24.5M
  • Earning Date
  • PFAI 10-31-2025
  • RANI 11-13-2025
  • Dividend Yield
  • PFAI N/A
  • RANI N/A
  • EPS Growth
  • PFAI N/A
  • RANI N/A
  • EPS
  • PFAI 0.03
  • RANI N/A
  • Revenue
  • PFAI $3,289,862.00
  • RANI $1,200,000.00
  • Revenue This Year
  • PFAI N/A
  • RANI N/A
  • Revenue Next Year
  • PFAI N/A
  • RANI N/A
  • P/E Ratio
  • PFAI $118.97
  • RANI N/A
  • Revenue Growth
  • PFAI 56.60
  • RANI N/A
  • 52 Week Low
  • PFAI $1.30
  • RANI $0.39
  • 52 Week High
  • PFAI $4.93
  • RANI $2.81
  • Technical
  • Relative Strength Index (RSI)
  • PFAI N/A
  • RANI 92.92
  • Support Level
  • PFAI N/A
  • RANI $0.46
  • Resistance Level
  • PFAI N/A
  • RANI $0.50
  • Average True Range (ATR)
  • PFAI 0.00
  • RANI 0.11
  • MACD
  • PFAI 0.00
  • RANI 0.08
  • Stochastic Oscillator
  • PFAI 0.00
  • RANI 66.32

About PFAI Pinnacle Food Group Limited Class A Common Shares

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: